Безводинских Александр Игоревич
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Безводинских Александр Игоревич has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Alexander I. Bezvodinskikh
Pavlov First Saint Petersburg State Medical University
1 shared publication - Anastasiya V. Vladykina
First Saint Petersburg State Medical University named after Academician I.P. Pavlov
1 shared publication - Andrey A. Gotovchikov
Pavlov First Saint Petersburg State Medical University
1 shared publication - Natalia A. Totolyan
Pavlov First Saint Petersburg State Medical University
1 shared publication - Yana B. Kushnir
St. Petersburg Pasteur Institute
1 shared publication Тотолян Наталья Агафоновна
Первый Санкт-Петербургский государственный медицинский университет имени академика И. П. Павлова
1 shared publication
Latest Publications
- Open Access
- 15 December 2023
- Published by Baltic Medical Education Center in Marine Medicine
- Vol. 9 (4) , 97-106
Clinical cases of “MR-negative” myelopathy amid SARS-CoV-2 infection
INTRODUCTION. Neurological complications are often observed in patients with a new coronavirus infection. Cerebrovascular diseases prevail among them. There is damage to the peripheral nervous system and spinal cord of various kind, including inflammatory and vascular myelopathy. The incidence of myelopathy syndrome among all neurological complications of the new coronavirus infection reaches 3%. OBJECTIVE. To characterize clinical and instrumental features of the rare case – “МR-negative” myelopathy amid SARS-CoV-2 infection. MATERIALS AND METHODS. The article describes a clinical case of myelopathy, associated with COVID-19 without structural changes in the spinal cord on MR-imaging using standard pulse sequences, however, visualized via spinal tractography. CONCLUSION. COVID-19 associated myelopathy is one of the characteristic complications amid the new coronavirus infection. To verify “MR-negative” damage to the central nervous system in COVID-19, advanced protocols of MRI studies might be used, including the promising method – МR-tractography.
- 15 December 2023
- Published by Baltic Medical Education Center in Marine Medicine
- Vol. 9 (4) , 97-106
Open AccessClinical cases of “MR-negative” myelopathy amid SARS-CoV-2 infection
INTRODUCTION. Neurological complications are often observed in patients with a new coronavirus infection. Cerebrovascular diseases prevail among them. There is damage to the peripheral nervous system and spinal cord of various kind, including inflammatory and vascular myelopathy. The incidence of myelopathy syndrome among all neurological complications of the new coronavirus infection reaches 3%. OBJECTIVE. To characterize clinical and instrumental features of the rare case – “МR-negative” myelopathy amid SARS-CoV-2 infection. MATERIALS AND METHODS. The article describes a clinical case of myelopathy, associated with COVID-19 without structural changes in the spinal cord on MR-imaging using standard pulse sequences, however, visualized via spinal tractography. CONCLUSION. COVID-19 associated myelopathy is one of the characteristic complications amid the new coronavirus infection. To verify “MR-negative” damage to the central nervous system in COVID-19, advanced protocols of MRI studies might be used, including the promising method – МR-tractography.